Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia · Delayed Price · Currency is AUD 0.1650
+0.0050 (3.13%)
Jul 31, 2026, 4:10 PM AEST
ASX:PAR Stock Forecast
ASX-PAR's stock price has decreased by -57.14% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 analysts polled by S&P Global, ASX:PAR stock has a consensus rating of "Strong Buy" and an average price target of $1.10. The average 1-year stock price forecast is 566.67% higher than the current stock price, while the lowest is $0.45 (+172.73%) and the highest is $1.74 (+954.55%).
Price Target: $1.10 (+566.67%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jun 18, 2026.
Analyst Ratings
The average analyst rating for ASX:PAR stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Apr '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bell Potter | Bell Potter | Buy Maintains $0.45 | Buy | Maintains | $0.45 | +172.73% | Jun 18, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.09
from -0.06
EPS Next Year
-0.09
from -0.09
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.